![Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer | Clinical and Translational Medicine | Full Text Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer | Clinical and Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40169-019-0255-4/MediaObjects/40169_2019_255_Fig1_HTML.png)
Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer | Clinical and Translational Medicine | Full Text
![How I investigate basophilia in daily practice - Feriel - 2020 - International Journal of Laboratory Hematology - Wiley Online Library How I investigate basophilia in daily practice - Feriel - 2020 - International Journal of Laboratory Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d8d7736f-f1da-4f66-9fb8-c91fd19aa2ff/ijlh13146-fig-0001-m.jpg)
How I investigate basophilia in daily practice - Feriel - 2020 - International Journal of Laboratory Hematology - Wiley Online Library
![Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer | Clinical and Translational Medicine | Full Text Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer | Clinical and Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40169-019-0255-4/MediaObjects/40169_2019_255_Fig4_HTML.png)
Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer | Clinical and Translational Medicine | Full Text
![Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in](https://www.ahajournals.org/cms/asset/adc2cf65-917e-4fdb-8bda-155bdc143a81/jah35977-fig-0001.png)